Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr:110:206.
doi: 10.1016/j.jhin.2020.12.011. Epub 2020 Dec 21.

Potential drawbacks of SARS-CoV-2 seroprevalence surveys

Affiliations
Comment

Potential drawbacks of SARS-CoV-2 seroprevalence surveys

G Lippi. J Hosp Infect. 2021 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Galanis P., Vraka I., Fragkou D., Bilali A., Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis. J Hosp Infect. 2020 doi: 10.1016/j.jhin.2020.11.008. - DOI - PMC - PubMed
    1. Cao S., Gan Y., Wang C., Bachmann M., Wei S., Gong J. Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nat Commun. 2020;11:5917. - PMC - PubMed
    1. Patel M.M., Thornburg N.J., Stubblefield W.B., Talbot H.K., Coughlin M.M., Feldstein L.R. Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee. JAMA. 2020;324:1781–1782. - PMC - PubMed
    1. Ioannidis J.P.A. Global perspective of COVID-19 epidemiology for a full-cycle pandemic. Eur J Clin Invest. 2020;50:e13423. - PMC - PubMed
    1. Bohn M.K., Loh T.P., Wang C.B., Mueller R., Koch D., Sethi S. IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020;58:2001–2008. - PubMed

Substances